Hughes Financial Services’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1
Closed -$40 1846
2026
Q1
$40 Sell
1
-70
-99% -$1.51K ﹤0.01% 1491
2025
Q4
$1.78K Buy
+71
New +$1.67K ﹤0.01% 582

Other funds holding APLS

Hughes Financial Services's APLS Position: Q2 2026 in Review

Hughes Financial Services sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1 share — an estimated $40 sold.

Hughes Financial Services first reported a position in APLS in Q4 2025 and held it in 2 quarters. The position peaked at $1.78K in Q4 2025. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Hughes Financial Services reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Hughes Financial Services sold 1 Apellis Pharmaceuticals share in Q2 2026, an estimated $40.
  • Hughes Financial Services first reported a position in Apellis Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Hughes Financial Services's Apellis Pharmaceuticals position peaked at $1.78K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.